Literature DB >> 13790483

Use of thioridazine (mellaril) in a variety of clinical settings.

A L JONES, D J LEWIS, A MILLER.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; TRANQUILIZING AGENTS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13790483      PMCID： PMC1938744     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  TP-21, a new phenothiazine.

Authors:  S COHEN
Journal:  Am J Psychiatry       Date:  1958-10       Impact factor: 18.112

2.  Imipramine, a clinical evaluation in a variety of settings.

Authors:  A MILLER; E F BAKER; D LEWIS; A JONES
Journal:  Can Psychiatr Assoc J       Date:  1960-07

3.  The effect of thioridazine (mellaril) on mental syndromes. Comparison with chlorpromazine and promazine.

Authors:  H AZIMA; H DUROST; D ARTHURS
Journal:  Can Med Assoc J       Date:  1959-10-01       Impact factor: 8.262

4.  Thioridazine (mellaril) in the treatment of chronic schizophrenics.

Authors:  J A BARSA; J C SAUNDERS
Journal:  Am J Psychiatry       Date:  1960-05       Impact factor: 18.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.